0.010482 0.006052 0.000000 0.000000 0.012104 0.000000 0.000000 0.000000 0.007645 0.00000 0.00000 0.00000 Maenaka, K. Juji, T. Stuart, D.I. Jones, E.Y. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 12 90.00 90.00 120.00 95.400 95.400 130.800 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Structure Fold.Des. FODEFH 1263 0969-2126 7 391 398 10.1016/S0969-2126(99)80052-5 10196125 Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I. 1999 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 288 1 MIRRORS IMAGE PLATE 1996-10 FUJI SINGLE WAVELENGTH M x-ray 1 1.0 1.0 BL-6A Photon Factory 1.0 1.0 SYNCHROTRON PHOTON FACTORY BEAMLINE BL-6A 28189.141 P58 KILLER CELL INHIBITORY RECEPTOR EXTRACELLULAR REGION 1 man polymer KIR2DL3 no no HEGVHRKPSLLAHPGPLVKSEETVILQCWSDVRFQHFLLHREGKFKDTLHLIGEHHDGVSKANFSIGPMMQDLAGTYRCY GSVTHSPYQLSAPSDPLDIVITGLYEKPSLSAQPGPTVLAGESVTLSCSSRSSYDMYHLSREGEAHERRFSAGPKVNGTF QADFPLGPATHGGTYRCFGSFRDSPYEWSNSSDPLLVSVTGNPSNSWPSPTEPSSETGNPRHLHAAAEQKLISEEDLNLD LVPRGSSSHHHHHHSSG HEGVHRKPSLLAHPGPLVKSEETVILQCWSDVRFQHFLLHREGKFKDTLHLIGEHHDGVSKANFSIGPMMQDLAGTYRCY GSVTHSPYQLSAPSDPLDIVITGLYEKPSLSAQPGPTVLAGESVTLSCSSRSSYDMYHLSREGEAHERRFSAGPKVNGTF QADFPLGPATHGGTYRCFGSFRDSPYEWSNSSDPLLVSVTGNPSNSWPSPTEPSSETGNPRHLHAAAEQKLISEEDLNLD LVPRGSSSHHHHHHSSG A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample CLONING BY PCR NATURAL KILLER CELL BL21 CELL SURFACE NKAT2 9606 Homo sapiens MEDIA AND PERIPLASMIC SPACE NKAT2 562 Escherichia coli BL21 PLYSS ESCHERICHIA COLI PLASMID PKMATHNK2 1 3.05 60 DATA WERE COLLECTED USING WEISSENBERG METHOD. 7.5 pH 7.5 diffrn_radiation diffrn_source repository Initial release Version format compliance Version format compliance Data collection 1 0 1999-01-27 1 1 2008-03-24 1 2 2011-07-13 1 3 2018-06-13 _diffrn_radiation.pdbx_diffrn_protocol _diffrn_source.pdbx_wavelength_list Y BNL 1999-01-18 REL REL n 1 1 A n 2 2 A n 3 3 A n 4 4 A HIS 5 n 5 HIS 5 A ARG 6 n 6 ARG 6 A LYS 7 n 7 LYS 7 A PRO 8 n 8 PRO 8 A SER 9 n 9 SER 9 A LEU 10 n 10 LEU 10 A LEU 11 n 11 LEU 11 A ALA 12 n 12 ALA 12 A HIS 13 n 13 HIS 13 A PRO 14 n 14 PRO 14 A GLY 15 n 15 GLY 15 A PRO 16 n 16 PRO 16 A LEU 17 n 17 LEU 17 A VAL 18 n 18 VAL 18 A LYS 19 n 19 LYS 19 A SER 20 n 20 SER 20 A GLU 21 n 21 GLU 21 A GLU 22 n 22 GLU 22 A THR 23 n 23 THR 23 A VAL 24 n 24 VAL 24 A ILE 25 n 25 ILE 25 A LEU 26 n 26 LEU 26 A GLN 27 n 27 GLN 27 A CYS 28 n 28 CYS 28 A TRP 29 n 29 TRP 29 A SER 30 n 30 SER 30 A ASP 31 n 31 ASP 31 A VAL 32 n 32 VAL 32 A ARG 33 n 33 ARG 33 A PHE 34 n 34 PHE 34 A GLN 35 n 35 GLN 35 A HIS 36 n 36 HIS 36 A PHE 37 n 37 PHE 37 A LEU 38 n 38 LEU 38 A LEU 39 n 39 LEU 39 A HIS 40 n 40 HIS 40 A ARG 41 n 41 ARG 41 A GLU 42 n 42 GLU 42 A GLY 43 n 43 GLY 43 A LYS 44 n 44 LYS 44 A PHE 45 n 45 PHE 45 A LYS 46 n 46 LYS 46 A ASP 47 n 47 ASP 47 A THR 48 n 48 THR 48 A LEU 49 n 49 LEU 49 A HIS 50 n 50 HIS 50 A LEU 51 n 51 LEU 51 A ILE 52 n 52 ILE 52 A GLY 53 n 53 GLY 53 A GLU 54 n 54 GLU 54 A HIS 55 n 55 HIS 55 A HIS 56 n 56 HIS 56 A ASP 57 n 57 ASP 57 A GLY 58 n 58 GLY 58 A VAL 59 n 59 VAL 59 A SER 60 n 60 SER 60 A LYS 61 n 61 LYS 61 A ALA 62 n 62 ALA 62 A ASN 63 n 63 ASN 63 A PHE 64 n 64 PHE 64 A SER 65 n 65 SER 65 A ILE 66 n 66 ILE 66 A GLY 67 n 67 GLY 67 A PRO 68 n 68 PRO 68 A MET 69 n 69 MET 69 A MET 70 n 70 MET 70 A GLN 71 n 71 GLN 71 A ASP 72 n 72 ASP 72 A LEU 73 n 73 LEU 73 A ALA 74 n 74 ALA 74 A GLY 75 n 75 GLY 75 A THR 76 n 76 THR 76 A TYR 77 n 77 TYR 77 A ARG 78 n 78 ARG 78 A CYS 79 n 79 CYS 79 A TYR 80 n 80 TYR 80 A GLY 81 n 81 GLY 81 A SER 82 n 82 SER 82 A VAL 83 n 83 VAL 83 A THR 84 n 84 THR 84 A HIS 85 n 85 HIS 85 A SER 86 n 86 SER 86 A PRO 87 n 87 PRO 87 A TYR 88 n 88 TYR 88 A GLN 89 n 89 GLN 89 A LEU 90 n 90 LEU 90 A SER 91 n 91 SER 91 A ALA 92 n 92 ALA 92 A PRO 93 n 93 PRO 93 A SER 94 n 94 SER 94 A ASP 95 n 95 ASP 95 A PRO 96 n 96 PRO 96 A LEU 97 n 97 LEU 97 A ASP 98 n 98 ASP 98 A ILE 99 n 99 ILE 99 A VAL 100 n 100 VAL 100 A ILE 101 n 101 ILE 101 A THR 102 n 102 THR 102 A GLY 103 n 103 GLY 103 A LEU 104 n 104 LEU 104 A TYR 105 n 105 TYR 105 A GLU 106 n 106 GLU 106 A LYS 107 n 107 LYS 107 A PRO 108 n 108 PRO 108 A SER 109 n 109 SER 109 A LEU 110 n 110 LEU 110 A SER 111 n 111 SER 111 A ALA 112 n 112 ALA 112 A GLN 113 n 113 GLN 113 A PRO 114 n 114 PRO 114 A GLY 115 n 115 GLY 115 A PRO 116 n 116 PRO 116 A THR 117 n 117 THR 117 A VAL 118 n 118 VAL 118 A LEU 119 n 119 LEU 119 A ALA 120 n 120 ALA 120 A GLY 121 n 121 GLY 121 A GLU 122 n 122 GLU 122 A SER 123 n 123 SER 123 A VAL 124 n 124 VAL 124 A THR 125 n 125 THR 125 A LEU 126 n 126 LEU 126 A SER 127 n 127 SER 127 A CYS 128 n 128 CYS 128 A SER 129 n 129 SER 129 A SER 130 n 130 SER 130 A ARG 131 n 131 ARG 131 A SER 132 n 132 SER 132 A SER 133 n 133 SER 133 A TYR 134 n 134 TYR 134 A ASP 135 n 135 ASP 135 A MET 136 n 136 MET 136 A TYR 137 n 137 TYR 137 A HIS 138 n 138 HIS 138 A LEU 139 n 139 LEU 139 A SER 140 n 140 SER 140 A ARG 141 n 141 ARG 141 A GLU 142 n 142 GLU 142 A GLY 143 n 143 GLY 143 A GLU 144 n 144 GLU 144 A ALA 145 n 145 ALA 145 A HIS 146 n 146 HIS 146 A GLU 147 n 147 GLU 147 A ARG 148 n 148 ARG 148 A ARG 149 n 149 ARG 149 A PHE 150 n 150 PHE 150 A SER 151 n 151 SER 151 A ALA 152 n 152 ALA 152 A GLY 153 n 153 GLY 153 A PRO 154 n 154 PRO 154 A LYS 155 n 155 LYS 155 A VAL 156 n 156 VAL 156 A ASN 157 n 157 ASN 157 A GLY 158 n 158 GLY 158 A THR 159 n 159 THR 159 A PHE 160 n 160 PHE 160 A GLN 161 n 161 GLN 161 A ALA 162 n 162 ALA 162 A ASP 163 n 163 ASP 163 A PHE 164 n 164 PHE 164 A PRO 165 n 165 PRO 165 A LEU 166 n 166 LEU 166 A GLY 167 n 167 GLY 167 A PRO 168 n 168 PRO 168 A ALA 169 n 169 ALA 169 A THR 170 n 170 THR 170 A HIS 171 n 171 HIS 171 A GLY 172 n 172 GLY 172 A GLY 173 n 173 GLY 173 A THR 174 n 174 THR 174 A TYR 175 n 175 TYR 175 A ARG 176 n 176 ARG 176 A CYS 177 n 177 CYS 177 A PHE 178 n 178 PHE 178 A GLY 179 n 179 GLY 179 A SER 180 n 180 SER 180 A PHE 181 n 181 PHE 181 A ARG 182 n 182 ARG 182 A ASP 183 n 183 ASP 183 A SER 184 n 184 SER 184 A PRO 185 n 185 PRO 185 A TYR 186 n 186 TYR 186 A GLU 187 n 187 GLU 187 A TRP 188 n 188 TRP 188 A SER 189 n 189 SER 189 A ASN 190 n 190 ASN 190 A SER 191 n 191 SER 191 A SER 192 n 192 SER 192 A ASP 193 n 193 ASP 193 A PRO 194 n 194 PRO 194 A LEU 195 n 195 LEU 195 A LEU 196 n 196 LEU 196 A VAL 197 n 197 VAL 197 A SER 198 n 198 SER 198 A VAL 199 n 199 VAL 199 A THR 200 n 200 THR 200 A GLY 201 n 201 GLY 201 A ASN 202 n 202 ASN 202 A PRO 203 n 203 PRO 203 A n 204 204 A n 205 205 A n 206 206 A n 207 207 A n 208 208 A n 209 209 A n 210 210 A n 211 211 A n 212 212 A n 213 213 A n 214 214 A n 215 215 A n 216 216 A n 217 217 A n 218 218 A n 219 219 A n 220 220 A n 221 221 A n 222 222 A n 223 223 A n 224 224 A n 225 225 A n 226 226 A n 227 227 A n 228 228 A n 229 229 A n 230 230 A n 231 231 A n 232 232 A n 233 233 A n 234 234 A n 235 235 A n 236 236 A n 237 237 A n 238 238 A n 239 239 A n 240 240 A n 241 241 A n 242 242 A n 243 243 A n 244 244 A n 245 245 A n 246 246 A n 247 247 A n 248 248 A n 249 249 A n 250 250 A n 251 251 A n 252 252 A n 253 253 A n 254 254 A n 255 255 A n 256 256 A n 257 257 A author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -0.5000000000 -0.8660254038 0.0000000000 -0.8660254038 0.5000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 9_765 -x+2,-x+y+1,-z+1/3 crystal symmetry operation 143.1000000000 82.6188235210 43.6000000000 A O VAL 18 A O VAL 18 A N VAL 100 A N VAL 100 A O VAL 24 A O VAL 24 A N ILE 66 A N ILE 66 A O ASP 47 A O ASP 47 A N ARG 41 A N ARG 41 A O HIS 36 A O HIS 36 A N SER 82 A N SER 82 A O GLY 75 A O GLY 75 A N ILE 99 A N ILE 99 A O SER 109 A O SER 109 A N SER 129 A N SER 129 A O VAL 124 A O VAL 124 A N GLY 167 A N GLY 167 A O MET 136 A O MET 136 A N SER 180 A N SER 180 A O GLY 173 A O GLY 173 A N VAL 197 A N VAL 197 1 A HIS 1 A HIS 1 1 Y 1 A GLU 2 A GLU 2 1 Y 1 A GLY 3 A GLY 3 1 Y 1 A VAL 4 A VAL 4 1 Y 1 A SER 204 A SER 204 1 Y 1 A ASN 205 A ASN 205 1 Y 1 A SER 206 A SER 206 1 Y 1 A TRP 207 A TRP 207 1 Y 1 A PRO 208 A PRO 208 1 Y 1 A SER 209 A SER 209 1 Y 1 A PRO 210 A PRO 210 1 Y 1 A THR 211 A THR 211 1 Y 1 A GLU 212 A GLU 212 1 Y 1 A PRO 213 A PRO 213 1 Y 1 A SER 214 A SER 214 1 Y 1 A SER 215 A SER 215 1 Y 1 A GLU 216 A GLU 216 1 Y 1 A THR 217 A THR 217 1 Y 1 A GLY 218 A GLY 218 1 Y 1 A ASN 219 A ASN 219 1 Y 1 A PRO 220 A PRO 220 1 Y 1 A ARG 221 A ARG 221 1 Y 1 A HIS 222 A HIS 222 1 Y 1 A LEU 223 A LEU 223 1 Y 1 A HIS 224 A HIS 224 1 Y 1 A ALA 225 A ALA 225 1 Y 1 A ALA 226 A ALA 226 1 Y 1 A ALA 227 A ALA 227 1 Y 1 A GLU 228 A GLU 228 1 Y 1 A GLN 229 A GLN 229 1 Y 1 A LYS 230 A LYS 230 1 Y 1 A LEU 231 A LEU 231 1 Y 1 A ILE 232 A ILE 232 1 Y 1 A SER 233 A SER 233 1 Y 1 A GLU 234 A GLU 234 1 Y 1 A GLU 235 A GLU 235 1 Y 1 A ASP 236 A ASP 236 1 Y 1 A LEU 237 A LEU 237 1 Y 1 A ASN 238 A ASN 238 1 Y 1 A LEU 239 A LEU 239 1 Y 1 A ASP 240 A ASP 240 1 Y 1 A LEU 241 A LEU 241 1 Y 1 A VAL 242 A VAL 242 1 Y 1 A PRO 243 A PRO 243 1 Y 1 A ARG 244 A ARG 244 1 Y 1 A GLY 245 A GLY 245 1 Y 1 A SER 246 A SER 246 1 Y 1 A SER 247 A SER 247 1 Y 1 A SER 248 A SER 248 1 Y 1 A HIS 249 A HIS 249 1 Y 1 A HIS 250 A HIS 250 1 Y 1 A HIS 251 A HIS 251 1 Y 1 A HIS 252 A HIS 252 1 Y 1 A HIS 253 A HIS 253 1 Y 1 A HIS 254 A HIS 254 1 Y 1 A SER 255 A SER 255 1 Y 1 A SER 256 A SER 256 1 Y 1 A GLY 257 A GLY 257 1 Y 1 9.08 1.50 119.30 128.38 A A A C N CA GLY PRO PRO 153 154 154 Y 1 A ARG 6 -38.50 165.49 1 A GLU 21 61.05 -42.49 1 A ARG 33 -95.74 36.74 1 A LYS 44 -48.13 -86.28 1 A LYS 46 -48.22 108.75 1 A ASP 57 -13.71 118.84 1 A PRO 68 -32.85 108.75 1 A THR 84 -9.30 -72.40 1 A HIS 85 -72.47 43.91 1 A SER 86 155.18 51.86 1 A PRO 87 -61.71 4.48 1 A GLN 113 -175.19 133.91 1 A VAL 118 -42.58 160.57 1 A SER 133 -87.19 49.95 1 A GLU 142 -15.16 101.12 1 A GLU 144 -37.47 125.74 1 A ALA 145 3.15 -88.41 1 A PHE 150 -172.60 138.19 1 A LYS 155 56.52 123.47 1 A VAL 156 -158.66 -39.10 1 A ASN 157 -157.27 29.83 1 A ALA 169 -56.84 104.07 1 A THR 170 -70.86 -90.44 1 A ASP 183 -22.03 -72.01 40.8 -0.40 -4.12 0.00 -0.40 0.00 0.81 REFINED BY X-PLOR, REFMAC AND CN 0.32 0.248 0.248 3.0 15.0 354 5896 5 79.4 RANDOM 1 THROUGHOUT 0 MOLECULAR REPLACEMENT FLAT MODEL 20 0.25 3.0 15.0 0 1541 0 0 1541 0.008 1.57 3.0 20.0 1B6U 6281 0 0.195 1 4.7 2.9 84.9 0.49 3.0 3.11 1.5 87.6 data reduction DENZO data scaling SCALEPACK refinement CNS 0.5 phasing CNS 0.5 P58 KILLER CELL INHIBITORY RECEPTOR CRYSTAL STRUCTURE OF THE HUMAN KILLER CELL INHIBITORY RECEPTOR (KIR2DL3) SPECIFIC FOR HLA-CW3 RELATED ALLELES 1 N N disulf 2.015 A CYS 28 A SG CYS 28 1_555 A CYS 79 A SG CYS 79 1_555 disulf 2.029 A CYS 128 A SG CYS 128 1_555 A CYS 177 A SG CYS 177 1_555 KILLER CELL INHIBITORY RECEPTOR KILLER CELL INHIBITORY RECEPTOR, NATURAL KILLER CELL, HLA, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I (MHC CLASS I), CELL SURFACE RECEPTOR, IMMUNOGLOBULIN SUPERFAMILY A HIS 13 A HIS 13 1 A PRO 14 A PRO 14 0.07 A GLN 113 A GLN 113 1 A PRO 114 A PRO 114 0.19 KI2L3_HUMAN UNP 1 1 P43628 MSLMVVSMVCVGFFLLQGAWPHEGVHRKPSLLAHPGPLVKSEETVILQCWSDVRFQHFLLHREGKFKDTLHLIGEHHDGV SKANFSIGPMMQDLAGTYRCYGSVTHSPYQLSAPSDPLDIVITGLYEKPSLSAQPGPTVLAGESVTLSCSSRSSYDMYHL SREGEAHERRFSAGPKVNGTFQADFPLGPATHGGTYRCFGSFRDSPYEWSNSSDPLLVSVTGNPSNSWPSPTEPSSETGN PRHLHVLIGTSVVIILFILLLFFLLHRWCCNKKNAVVMDQEPAGNRTVNREDSDEQDPQEVTYAQLNHCVFTQRKITRPS QRPKTPPTDIIVYTELPNAEP 22 245 1B6U 1 224 P43628 A 1 1 224 2 2 4 3 3 parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A LEU 17 A LEU 17 A LYS 19 A LYS 19 A VAL 100 A VAL 100 A THR 102 A THR 102 A VAL 24 A VAL 24 A SER 30 A SER 30 A SER 60 A SER 60 A ILE 66 A ILE 66 A ASP 47 A ASP 47 A ILE 52 A ILE 52 A HIS 36 A HIS 36 A GLU 42 A GLU 42 A GLY 75 A GLY 75 A SER 82 A SER 82 A LEU 97 A LEU 97 A ILE 99 A ILE 99 A SER 109 A SER 109 A SER 111 A SER 111 A SER 123 A SER 123 A SER 130 A SER 130 A PHE 160 A PHE 160 A PRO 168 A PRO 168 A MET 136 A MET 136 A ARG 141 A ARG 141 A GLY 173 A GLY 173 A SER 180 A SER 180 A LEU 195 A LEU 195 A VAL 197 A VAL 197 179 P 65 2 2